Pharma giant strikes deal to save breast cancer drug funding

Breast cancer radiology

The Swiss drug giant Novartis has struck a deal with NHS England to prevent one of its breast cancer treatments being axed from the cancer drugs fund.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here